SCHEMBL2913162

SCHEMBL2913162

COC(c1c(F)cccc1F)C1(C(C(=O)NC2CCCCC2)C2CCCCC2)Nc2cc(F)c(F)cc2N1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.42
MEN1 O00255 2/20 0.42
NPC1 O15118 8/20 0.38
RAB9A P51151 8/20 0.38
SMN1; SMN2 Q16637 5/20 0.37
TSHR P16473 1/20 0.36
NR3C1 P04150 1/20 0.36
PGR P06401 1/20 0.36
NR3C2 P08235 1/20 0.36
CYP3A4 P08684 2/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
KCNH2 Q12809 1/20 0.35
NR1H4 Q96RI1 1/20 0.35
LMNA P02545 1/20 0.35
POLB P06746 1/20 0.35
GAA P10253 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C19 P33261 1/20 0.35
HTR2B P41595 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2910028 0.88 SMN1; SMN2 (0.45) KMT2AMEN1NPC1RAB9ASMN1; SMN2
SCHEMBL2914472 0.85 MEN1 (0.36) KMT2AMEN1NPC1RAB9ASMN1; SMN2
SCHEMBL2912649 0.83 KMT2A (0.39) KMT2AMEN1NPC1RAB9ASMN1; SMN2
SCHEMBL2908003 0.83 KMT2A (0.39) KMT2AMEN1NPC1RAB9ASMN1; SMN2
SCHEMBL2915018 0.83 SMN1; SMN2 (0.41) KMT2AMEN1RAB9ASMN1; SMN2TSHR
SCHEMBL2912642 0.80 SMN1; SMN2 (0.43) KMT2AMEN1NPC1RAB9ASMN1; SMN2
SCHEMBL2307838 0.78 NR1H4 (0.41) NPC1RAB9ASMN1; SMN2TSHRCYP3A4
SCHEMBL2907592 0.78 NPC1 (0.42) KMT2AMEN1NPC1RAB9ASMN1; SMN2
SCHEMBL2913040 0.78 TSHR (0.44) KMT2AMEN1NPC1RAB9ASMN1; SMN2
SCHEMBL2906901 0.77 CNR1 (0.40) KMT2AMEN1NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2222645-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. Hoffmann-La Roche AG (CH) 2010-09-01 EP claimed
WO-2009062874-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2009-05-22 WO claimed